HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.0
  1. Home
  2. /Reaction

1-Hydroxybenzotriazole → HCID 44133332, compound

HRID 450125
Notes
Print preview

Reaction equation

HRID 450125 reaction equation
[F:1][C:2]1[CH:7]=[C:6]([I:8])[CH:5]=[CH:4][C:3]=1[NH:9][C:10]1[N:14]2[CH:15]=[N:16][CH:17]=[CH:18][C:13]2=[CH:12][C:11]=1[C:19]([OH:21])=O.CC1(C)[O:27][C@H:26]([CH2:28]NO)[CH2:25][O:24]1.C1C=CC2[N:40]([OH:41])N=NC=2C=1.CCN=C=NCCCN(C)C.Cl.CCN(C(C)C)C(C)C>CN(C=O)C>[OH:27][C@H:26]([CH2:25][OH:24])[CH2:28][O:41][NH:40][C:19]([C:11]1[CH:12]=[C:13]2[CH:18]=[CH:17][N:16]=[CH:15][N:14]2[C:10]=1[NH:9][C:3]1[CH:4]=[CH:5][C:6]([I:8])=[CH:7][C:2]=1[F:1])=[O:21]
ParticipantsProcedureWorkupSources & evidenceReaction notes

Participants

7

Reactant 5

HCID 757711-HydroxybenzotriazoleHCID 81531DiisopropylethylamineHCID 27239391,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochlorideHCID 23541087(S)-(+)-2,2-Dimethyl-4-hydroxyaminomethyl-1,3-dioxolaneHCID 672358207-(2-Fluoro-4-iodo-phenylamino)-pyrrolo[1,2-c]pyrimidine-6-carboxylic acid

Product 1

HCID 44133332
HCID 44133332, compound
Yield 20%

Reagents, catalysts & solvents 1

HCID 6228DimethylformamideSolvent

Procedure

7-(2-Fluoro-4-iodo-phenylamino)-pyrrolo[1,2-c]pyrimidine-6-carboxylic acid (90 mg, 0.23 mmol), O—(((R)-2,2-dimethyl-[1,3]dioxolan-4-ylmethyl)-hydroxylamine (35 mg, 0.23 mmol), HOBt (35 mg, 0.26 mmol), EDCI hydrochloride (50 mg, 0.26 mmol) and DIPEA (40 μL, 0.23 mmol) were dissolved in DMF (3 mL). The reaction was stirred at room temperature for 16 hours then concentrated in vacuo. The resultant residue was dissolved in ethyl acetate (10 mL), washed with aqueous saturated sodium bicarbonate solution (10 mL) and the aqueous fraction extracted twice with ethyl acetate (2×10 mL). The combined organic fractions were washed with brine, dried (MgSO4) and concentrated in vacuo. The resultant residue was dissolved in hydrochloric acid in dioxane (2 mL, 4M) and stirred at RT for 10 minutes. The reaction mixture was concentrated in vacuo and the resultant residue subjected to reverse phase HPLC (gradient 20-80% acetonitrile/water 0.1% formic acid, Phenominex gemini PhC6, 5 micron, 250×20 mm). The product was dissolved in ethyl acetate (5 mL), washed with aqueous saturated sodium bicarbonate solution (10 mL) and the aqueous fraction extracted twice with ethyl acetate (2×10 mL). The combined organic fractions were washed with brine, dried (MgSO4) and concentrated in vacuo to yield the title compound as a yellow solid (22 mg, 20%). NMR (d6-DMSO, 400 MHz) 11.39 (1H, s), 8.68 (1H, s), 7.99 (1H, s), 7.49 (1H, dd, J=10.9, 1.8 Hz), 7.41 (2H, s), 7.14-7.17 (1H, m), 6.74 (1H, s), 5.92 (1H, t, J=8.9 Hz), 4.80-4.81 (1H, m), 4.53 (1H, s), 3.80 (1H, dd, J=9.6, 3.6 Hz), 3.56-3.66 (2H, m). LCMS (Method A): RT=7.57 min, M+H+=487.

Workup

  1. concentrationthen concentrated in vacuo
  2. dissolutionThe resultant residue was dissolved in ethyl acetate (10 mL)
  3. washwashed with aqueous saturated sodium bicarbonate solution (10 mL)
  4. extractionthe aqueous fraction extracted twice with ethyl acetate (2×10 mL)
  5. washThe combined organic fractions were washed with brine
  6. dry with materialdried (MgSO4)
  7. concentrationconcentrated in vacuo
  8. dissolutionThe resultant residue was dissolved in hydrochloric acid in dioxane (2 mL, 4M)
  9. stirringstirred at RT for 10 minutes
  10. concentrationThe reaction mixture was concentrated in vacuo
  11. dissolutionThe product was dissolved in ethyl acetate (5 mL)
  12. washwashed with aqueous saturated sodium bicarbonate solution (10 mL)
  13. extractionthe aqueous fraction extracted twice with ethyl acetate (2×10 mL)
  14. washThe combined organic fractions were washed with brine
  15. dry with materialdried (MgSO4)
  16. concentrationconcentrated in vacuo

Sources & evidence

ORD record
ord-241bd5a3d40540c99942844cd368f107
Source dataset
uspto-grants-2013_07
DOI
10.6084/m9.figshare.5104873.v1
Patent number
US08486963B2

Reaction notes

Loading…

On this pageParticipantsProcedureWorkupSources & evidenceReaction notes